Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PDGFR antagonists(Platelet-derived growth factor receptor antagonists), PLK1 inhibitors(Polo like kinase 1 inhibitors), VEGFR2 antagonists(Vascular endothelial growth factor receptor 2 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | CN | - |